Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

Erratum

No authors listed

On page 358, There was an error in the legend of Figure 2. On page 373, There was an error in the Table 3.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regression of liver cirrhosis: Orthodoxy or paradigm shift?

Yu SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Personalized treatment of hepatitis B

Lok AS

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Budd-Chiari syndrome with multiple large regenerative nodules

Kim H, Nahm JH, Park YN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical implications of advances in liver regeneration

Kwon YJ, Lee KG, Choi D

Remarkable advances have been made recently in the area of liver regeneration. Even though liver regeneration after liver resection has been widely researched, new clinical applications have provided a better...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in the imaging of hepatocellular carcinoma

You MW, Kim SY, Kim KW, Lee SJ, Shin YM, Kim JH, Lee MG

The role of imaging is crucial for the surveillance, diagnosis, staging and treatment monitoring of hepatocellular carcinoma (HCC). Over the past few years, considerable technical advances were made in imaging...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Ha YJ, An JH, Shim JH, Yu ES, Kim JJ, Ha TY, Lee HC

Primary hepatic actinomycosis is one of the chronic abscess-forming infections of the liver. Accurate diagnosis is frequently delayed due to its indolent course and nonspecific clinical and radiological manifestations. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The cost of liver disease in Korea: methodology, data, and evidence

Chung W

BACKGROUND/AIMS: This study introduces methods for estimating the cost of liver disease and presents useful and reliable sources of data. The available evidence on the costs associated with liver disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

Yo IK, Kwon OS, Park JW, Lee JJ, Lee JH, Won IS, Na SY, Jang PK, Park PH, Choi DJ, Kim YS, Kim JH

BACKGROUND/AIMS: Liver stiffness (LS) as assessed by transient elastography (TE) can change longitudinally in patients with chronic hepatitis B (CHB). The aim of this study was to identify the factors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Kim JO, Jun DW, Tae HJ, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC, Hahm JS

Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Shin SW, Jeong WK, Lim S, Kim Y, Kim J

BACKGROUND/AIMS: To investigate sequential changes in laboratory markers after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) and the relationship of these changes to the severity of the underlying liver disease. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Lee HJ, Kang HJ, Kim KM, Yu ES, Kim KH, Kim SM, Kim TW, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS

BACKGROUND/AIMS: Fibroblast growth factor signaling is involved in hepatocarcinogenesis. The aim of this study was to determine the fibroblast growth factor receptor (FGFR) isotype expression in hepatocellular carcinoma (HCC) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Gu HR, Park SC, Choi SJ, Lee JC, Kim YC, Han CJ, Kim J, Yang KY, Kim YJ, Noh GY, No SH, Jeong JH

BACKGROUND/AIMS: Silibinin, the main component of silymarin, is used as a hepatoprotectant and exhibits anticancer effects against various cancer cells. This study evaluated the effects of a combination of silibinin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naive and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Jung SK, Kim KA, Ha SY, Lee HK, Kim YD, Lee BH, Paik WH, Kim JW, Bae WK, Kim NH, Lee JS, Jwa YJ

BACKGROUND/AIMS: This study investigated the antiviral effects of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue (NA)-naive and NA-experienced chronic hepatitis B (CHB) patients. METHODS: CHB patients treated with TDF monotherapy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of prolonged entecavir monotherapy in treatment-naive chronic hepatitis B patients exhibiting a partial virologic response to entecavir

Choi HN, Song JE, Lee HC, Jo HH, Lee CH, Kim BS

BACKGROUND/AIMS: The optimal management of patients exhibiting a partial virologic response (PVR) to entecavir (ETV) has not been determined . The aim of this study was to determine the long-term...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr